SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific informs about newspaper publication

16 Jul 2025 Evaluate
Pursuant to Regulation 30 the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sequent Scientific has enclosed copies of newspaper advertisement published in Financial Express (English) and Nava Telangana (Telugu) newspapers on July 16, 2025, intimating about the Fortieth Annual General Meeting scheduled to be held on Friday, August 8, 2025 at 4:00 pm (IST) to the shareholders along with procedure for e-voting, manner of registering email address etc. Copies of the aforesaid advertisements shall also be placed on the Company's website at: Shareholder Information - SeQuent.

The above information is a part of company’s filings submitted to BSE.

Viyash Scientific Share Price

253.40 1.50 (0.60%)
11-Jun-2026 09:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.90
Dr. Reddys Lab 1276.95
Cipla 1376.00
Zydus Lifesciences 1100.15
Lupin 2260.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×